NASDAQ
Bellicum Pharmaceuticals, Inc. (BLCM) has a interest coverage ratio of -586543.48x as of Friday, May 29, 2026. This represents a 37264.88% decrease compared to its 12-month average of -1569.77x. The interest coverage ratio measures how easily a company can pay interest on its outstanding debt from operating earnings.
No price data available for this timeframe.